Selective cyclooxygenase-2 inhibitors

[1] Adams J, 1996, J NEUROCHEM, V66, P6

[2] PURIFICATION, CHARACTERIZATION AND SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN-G/H SYNTHASE-1 AND SYNTHASE-2 EXPRESSED IN THE BACULOVIRUS SYSTEM [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (01): : 130 - 139

[3] Barnett JW, Eur. Pat Appl., Patent No. [714895, EP 714895]

[4] BATT DG, Patent No. 9610012

[5] Bertenshaw S. R., [No title captured], Patent No. [WO 9515316, 9515316]

[6] BESWICK PJ, Patent No. 9631509

[7] BLACK C, Patent No. 9636623

[8] BLACK C, Patent No. 9619469

[9] From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 725 - 730

[10] A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J]. INFLAMMATION RESEARCH, 1996, 45 (02) : 68 - 74

[1] Adams J, 1996, J NEUROCHEM, V66, P6

[2] PURIFICATION, CHARACTERIZATION AND SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN-G/H SYNTHASE-1 AND SYNTHASE-2 EXPRESSED IN THE BACULOVIRUS SYSTEM [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (01): : 130 - 139

[3] Barnett JW, Eur. Pat Appl., Patent No. [714895, EP 714895]

[4] BATT DG, Patent No. 9610012

[5] Bertenshaw S. R., [No title captured], Patent No. [WO 9515316, 9515316]

[6] BESWICK PJ, Patent No. 9631509

[7] BLACK C, Patent No. 9636623

[8] BLACK C, Patent No. 9619469

[9] From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 725 - 730

[10] A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J]. INFLAMMATION RESEARCH, 1996, 45 (02) : 68 - 74